Archive | Redefining Every Stage Investments (RESI) RSS feed for this section

Partnering Opens for RESI JPM & RESI London on Nov. 18

5 Nov

By Karen Deyo, VP of Product, Israel BD, LSN

karen-wpRESI London, held in person on December 4 at 11 Cavendish Square in London, followed by two-days of virtual partnering on December 5-6, and RESI JPM, taking place in San Francisco on January 13 at the Marriott Marquis, followed by three days of virtual partnering January 14-15 and January 21, offer unparalleled opportunities to connect with global investors. The partnering platform for both events opens on Monday, November 18, providing attendees with options to book both in-person and virtual meetings. Through the LSN Partnering Platform, startups can identify investors suited to their needs by sector, indication, stage of development, and other key criteria. Successful partnering takes preparation, with top companies typically sending over 100 meeting requests to relevant investors and following up frequently to secure impactful connections. Next week, we will be offering a free partnering tutorial to help you maximize your RESI London experience, and another in December focused on RESI JPM.

Free Partnering Tutorial Webinars

Understanding the RESI partnering system and using it to its maximum capabilities can greatly impact a company’s success at RESI. Join LSN staff as we walk you through our system and how it can help you identify partners who are the best fit for you, how to manage your outreach, our recommended strategy for following up, and how to take advantage of all of the content that we provide to ensure your best possible RESI experience.

  • November 12 – 10AM ET: Partnering Tutorial (RESI London) – Sign up
  • December 3 – 12PM ET: Partnering Tutorial (RESI JPM) – Sign up

RESI-London-2024-1100px

RESI-SF-2025-Banner-1100px

Amplified Sciences, Winner of the RESI Boston Pitch Challenge

5 Nov

Interview with Diana Caldwell, CEO of Amplified Sciences By Caitlin Dolegowski, Marketing Manager, LSN

DianaDiana Caldwell CaitiCaitlin Dolegowski

In this interview, we sit down with Diana Caldwell, CEO of Amplified Sciences and the first-place winner of the Innovator’s Pitch Challenge (IPC) at RESI Boston. Amplified Sciences stood out with their innovative approach, impressing both judges and attendees. Today, Diana shares insights into her company’s journey, their groundbreaking technology, and the experience of pitching at RESI. Join us as we dive into the story behind Amplified Sciences and what this win means for their future.

Interested in showcasing your innovation? Applications for the Innovator’s Pitch Challenge at RESI London and RESI JPM are open until this Friday, November 8th. Don’t miss the opportunity to pitch in front of a dedicated panel of investors, gain valuable feedback, and make lasting connections. Apply now to take your innovation to the next level.

Apply Pitch at RESI London Apply Pitch at RESI JPM

RESI-London-2024-1100px

RESI-SF-2025-Banner-1100px

Maximize Your Exposure to Life Science Startups: Exhibit @ RESI JPM

5 Nov

By Erika Wu, Business Development Manager, Global Tech Hubs, LSN

RESI JPM will take place at the Marriott Marquis in San Francisco during the JPM conference week. This conference provides a comprehensive in-person experience on January 14, where service providers can connect directly with early-stage life science and healthcare companies and investors. RESI offers a valuable opportunity for exhibitors, including CROs, CMOs, banks, and law and consultant firms to network with startups that are actively seeking partnerships for development and growth.

Eva Garland Consulting (EGC), a consultant firm specializing in grant proposal preparation and strategies was an exhibitor at RESI Boston. Review their shared insights in the video testimonial which highlights the unique networking opportunities and targeted connections that RESI offers.

RESI’s commitment to early-stage companies gives service providers a specialized platform to reach ideal clients in life sciences. CROs and CMOs have the chance to connect with preclinical therapeutics, labs with R&D space can meet startups in need of facilities, consultant firms provide strategy for grants, regulatory, as well as other areas, and life science-specific banks and law firms specializing in IP and term sheet negotiations can connect with founders seeking these services.

The RESI exhibition package includes a table for promotion and networking in the exhibit hall, along with prominent logo placement on the RESI website, program guide, and onsite signage. Exhibitors also receive complimentary registration to participate in the partnering platform and attend all conference events, maximizing their visibility and networking potential. Interested in reaching a broad audience of early-stage entrepreneurs at RESI JPM? Contact us at resi@lifesciencenation.com to learn more!

RESI-London-2024-1100px

RESI-SF-2025-Banner-1100px

Extended Pitch Time: RESI’s Innovator’s Pitch Challenge Gets an Upgrade! 

29 Oct

By Max Braht, Business Development Manager, LSN

Max-Braht-HeadshotLife Science Nation (LSN) announces enhancements to our Innovator’s Pitch Challenge (IPC) at RESI conferences, responding directly to your feedback for more presentation time.

New IPC Format

Participants will now enjoy a 6-minute presentation followed by a 7-minute Q&A session with sector-specific investor judges. Additionally, each company will have access to table and poster space (excluding RESI London) and a standard 3-day ticket for both in-person and virtual partnering. This extended format allows companies to provide a more comprehensive overview of their investment readiness and engage in deeper discussions with potential investors.

IPC-Article-Image

Upcoming Events

  • RESI London 2024, December 4 (In-person); 5-6 (Virtual Partnering Only)
  • RESI JPM 2025, January 14 (In-person); 15-16 (Virtual Partnering Only)

Join us for the Innovator’s Pitch Challenge at:

Apply to Pitch at RESI London Apply to Pitch at RESI JPM

Due to limited pitch slots, we encourage you to apply early.

For questions or to apply, please reach out to our team at salescore@lifesciencenation.com. Don’t miss this opportunity to showcase your innovations and connect with potential investors!

RESI-London-2024-1100px

RESI-SF-2025-Banner-1100px

RESI London 2024: A Global Gathering of Life Science Investors 

29 Oct

By Faith Patenaude, Investor Research Analyst, LSN

Faith

The upcoming Redefining Early Stage Investments (RESI) Conference in London is shaping up to be a remarkable event for life science innovators worldwide. The conference will be taking place in-person on December 4 at 11 Cavendish Square, followed by virtual partnering on December 5-6. RESI London 2024 is set to connect ambitious life science start-ups with a diverse array of early-stage investors and strategic partners from across the globe.

Featured RESI London Investors

RESI-London-CI

RESI’s reach goes well beyond the UK. While London-based investors like Delin Ventures, Boost Capital Partners, and Calculus Capital will be actively participating, RESI London 2024 will also welcome an extensive lineup of international firms, opening doors to far-reaching networks and growth opportunities.

European representation will be especially strong. In addition to local players, leading firms such as M Ventures from The Netherlands and CVX Ventures from Denmark will be present, providing crucial European connections for attending start-ups.

But the participation doesn’t stop at Europe. From the United States, esteemed investors like Optum Ventures and Lifespan Vision Ventures will take part in the event. Expanding beyond the Eastern Hemisphere, attendees can connect with firms such as Teijin Pharma from Japan, and Brandon Capital Partners from Australia, all of whom are eager to explore new partnerships with innovative life science start-ups.

RESI London 2024 offers an unparalleled chance to engage with a diverse and globally-minded group of investors. Interested in joining? Contact us at resi@lifesciencenation.com or click here to learn more.

RESI-London-2024-1100px

RESI-SF-2025-Banner-1100px

Innovating Together: Insights from BioJapan 2024 with Life Science Nation 

29 Oct

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

A few weeks ago, Life Science Nation (LSN) headed to Yokohama to attend BioJapan 2024 from October 9-11, 2024. As one of the largest partnering conferences in Asia focused on the life sciences industry, this year’s event attracted over 18,000 attendees over the course of 3 days. For many years, BioJapan has served as a useful platform for LSN to expand its international network, including startups, investors/strategic partners, bioclusters, service providers, and more.

This year, LSN was invited by Life Science Incubation Council (LSIC) to join a seminar on “how life science startups in Japan can work together with global partners”. Founded in 2022, LSIC is a Japanese organization that has created a platform on which key players in the sector such as start-ups, VCs, pharmaceutical companies, medical device companies and government organizations can work together to develop innovative technology seeds, aiming towards commercialization of these technologies. LSN has signed an MOU with LSIC earlier this year to collaborate on initiatives to support the life sciences ecosystem in Japan.

Biojp

The seminar took place on the last day of BioJapan, Friday, October 11, and featured the following panelists: Claire Jeong (Life Science Nation), Hélène Moore (BIOQuébec), Angela Kukula (MedCity), and Toru Seo (NewSight Tech Angels). The seminar presented an opportunity for each panelist to shed more light into their activities and their respective ecosystems, and to provide guidance on how Japanese companies can establish better relationships with international partners for expanding their business on an international scale.

Biojp2

Shigehiro Asano (National Cerebral and Cardiovascular Center, Osaka), Claire Jeong (VP of Investor Research, Asia BD), Toru Seo (NewSight Tech Angels), Nao Yoshizawa (Life Science Incubation Council), Hélène Moore (BIOQuébec), Angela Kukula (MedCity), Tsuneaki Sakata (Osaka University / Biocommunity Kansai BiocK)

It was a great honor for LSN to share the panel with key industry experts and engage with more connections in Japan. LSN looks forward to continue providing a platform for life science and healthcare startups to connect with investors and strategic partners. Whether you are a startup seeking to identify more international investors and partners, or an investor seeking more international dealflow, please contact RESI@lifesciencenation.com if you are interested in learning more about how LSN can be helpful.

As with previous years, this year’s BioJapan was a very productive and well-executed event, and we look forward to returning next year!

RESI-London-2024-1100px

RESI-SF-2025-Banner-1100px

How to Succeed in Company Presentations/Pitches at Partnering Conferences: The Drive to Win, and What It Takes

22 Oct

Interview with Dennis Ford, Founder & CEO of Life Science Nation (LSN) By Claire Jeong, CCO, VP of Investor Research, Asia BD, LSN

DF-News-09142022Dennis Ford Claire-newClaire Jeong

In the high-stakes world of fundraising, competition is fierce, and success demands more than just a good idea—it requires strategy, persistence, and grit. At Life Science Nation (LSN), participant feedback helps us fine-tune our events to serve their needs better. Recently, concerns were raised about the fairness of the Innovator’s Pitch Challenge (IPC) at RESI Boston. In this forum, companies pitch to a panel of investor judges and audience, with some alleging that participants may have “gamed the system.” These observations point to a larger conversation about business dynamics—where determination often trumps traditional notions of fairness. In this candid interview, LSN’s CEO, Dennis Ford, explores the fine line between integrity, innovation, and the entrepreneurial hustle that drives results in a competitive environment.

Claire Jeong (CJ): What differentiates CEOs who succeed in fundraising from those who struggle, particularly in the context of RESI and the Innovator’s Pitch Challenge?
Dennis Ford (DF): The RESI IPC is a microcosm of the real-world fundraising landscape. Some CEOs adopt a proactive approach, while others wait for investors or licensing partners to approach them. The passive ones tend to wait for things to happen to them, while the proactive CEOs are out there making things happen. Just like in the real world, the ones who seize every opportunity are the ones who tend to succeed.

CJ: What mindset shift do you believe is critical for startup CEOs transitioning from academia to a competitive fundraising environment?
DF: Many startup CEOs, particularly those coming from academia, think that paying an entry fee, being selected to pitch, and setting up a poster is enough. They expect investors to naturally flock to them. However, that’s only a minimal effort. To truly excel at a partnering event like RESI, you need to actively seek out opportunities—engage with everyone who walks by, identify investors, and make sure they know who you are. This transition mirrors the shift from academia to the business world, where you’re no longer a scientist—you’re a salesperson, marketer, and business developer.

CJ: How important is balancing compelling science with a determined business development strategy in the fundraising process?
DF: Striking the right balance is essential. In fact, we’ve seen some of the more aggressive participants in the IPC go as far as asking people for their RESI dollars, getting colleagues to donate theirs, and working the system to gain attention. This is the point of the IPC – getting CEOs to put themselves out there and speak to as many attendees as possible. It gives companies many opportunities to practice their pitch, network, and push CEOs to tell as many people as possible their story. While it might not seem “fair” to some, this aggressive approach mirrors the cutthroat nature of fundraising. CEOs need to understand that they’re no longer just researchers—they’re operating in a startup environment where they need to fight for every dollar, every collaboration, and every opportunity.

CJ: Can you share examples of how startup CEOs who took a more aggressive approach achieved success at RESI or in their broader fundraising efforts?
DF: The CEOs who reframe their mindset and adopt a more aggressive approach are often the ones who succeed. The combination of preparation, hustle, and compelling science gives them a real chance. If a CEO lacks either preparation or hustle, the likelihood of failure increases. That’s why the failure rate in life science startups is so high. The process of translating science into a viable product is hard, and having a team willing to fully commit is even harder. But when you have that combination, you’re much more likely to succeed.

CJ: What advice would you give to CEOs who are hesitant to take an aggressive approach when engaging with investors at events like RESI?
DF: The hesitation is understandable, but this isn’t an environment where waiting around will get you anywhere. If you want to succeed, you have to go after it relentlessly. Yes, the market can be frustrating, and investors can be difficult, but those who adapt and push beyond their comfort zones are the ones who will secure funding. CEOs should view it as a way to practice their elevator pitch and refine their story – speaking to 100 people in the quest to gain RESI cash will help companies refine their pitch a lot more than if they stick to only speaking to people with whom they have scheduled meetings.

CJ: How does participation in the RESI IPC competition reflect the real-world challenges life science startups face in fundraising?
DF: The RESI IPC mirrors the fundraising marketplace perfectly. We’ve run about 50 of these competitions over the last twelve years, and the pattern is always the same—some participants hustle hard, others take a more passive approach, and many learn and improve as they go. What’s interesting is that the startups who win IPC prizes—based on votes from both RESI dollars and judges—tend to be the ones who also succeed outside of the competition. They’ve become guerrilla marketers and street fighters, combining that tenacity with a solid product and milestones. Success in the technology and innovation space has always required that mix of drive and substance, and it always will.

The RESI Innovator’s Pitch Challenge is not just a competition; it’s a testing ground for the broader fundraising landscape. It rewards those who balance science with the hustle, pushing past the perceived limits of fairness to carve out their path in the startup ecosystem. The lesson? If you want to succeed, you must be willing to fight for it—aggressively, intelligently, and relentlessly.

Apply Pitch at RESI London Apply Pitch at RESI JPM

RESI-London-2024-1100px

RESI-SF-2025-Banner-1100px